PIP provides up to £737 each month to nearly 140,000 people with these respiratory conditions
Asthma, pneumonia and over 20 other conditions affecting the lungs and respiratory system are supported by PIP.
Pulmonx (LUNG) Gets a Hold from Wells Fargo
In a report released today, Larry Biegelsen from Wells Fargo maintained a Hold rating on Pulmonx (LUNG – Research Report), with a price target ...
What People Living With COPD or Emphysema Need to Know About Available Treatments
More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This chronic lung ...
Pharmabiz20 小时
US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic ...
US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...